-transparent.png){kind=logo}
Coagulation factors II, VII, X, VII + X complex and anti-thrombin III were measured in 10 postmenopausal women before, during and after a four-month course of 20 microgram daily of ethinyl oestradiol, taken three weeks in four. Factors VII, X and VII + X complex rose significantly during treatment but only factor X levels were significantly elevated at the end of the four-month treatment period. There was no change in factor II or anti-thrombin III levels. These effects on coagulation factors during ethinyl oestradiol therapy are, in general, similar to those found during treatment with conjugated equine oestrogens and oestradiol valerate in a previous study from the same laboratory. It seems likely that equipotent doses of ethinyl oestradiol and 'natural' oestrogens have similar effects on these coagulation factors.
D J Hunter, and
A B Anderson, and
M Haddon
February 1984,
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
D J Hunter, and
A B Anderson, and
M Haddon
February 1989,
The Australian & New Zealand journal of obstetrics & gynaecology,
D J Hunter, and
A B Anderson, and
M Haddon
November 1948,
British medical journal,
D J Hunter, and
A B Anderson, and
M Haddon
October 1990,
British journal of obstetrics and gynaecology,
D J Hunter, and
A B Anderson, and
M Haddon
August 1983,
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics,
D J Hunter, and
A B Anderson, and
M Haddon
January 1999,
Haemostasis,
D J Hunter, and
A B Anderson, and
M Haddon
December 1982,
Clinical endocrinology,
D J Hunter, and
A B Anderson, and
M Haddon
October 1980,
Maturitas,
D J Hunter, and
A B Anderson, and
M Haddon
September 1997,
Zhonghua fu chan ke za zhi,
D J Hunter, and
A B Anderson, and
M Haddon
June 1999,
Climacteric : the journal of the International Menopause Society,
